SCHEMBL4928347

SCHEMBL4928347

C=CCOC(=O)C(=O)C=Cc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.61
ALDH1A1 P00352 7/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
MAPK1 P28482 2/20 0.58
KDM4E B2RXH2 2/20 0.55
GLA P06280 2/20 0.55
CYP3A4 P08684 1/20 0.49
CASP1 P29466 1/20 0.48
LMNA P02545 3/20 0.48
GAA P10253 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
HDAC3 O15379 1/20 0.47
TNKS O95271 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HCAR2 Q8TDS4 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4928343 1.00 MAPT (0.61) MAPTALDH1A1MEN1KMT2AMAPK1
SCHEMBL500262 0.86 CYP3A4 (0.51) MAPTALDH1A1MEN1KMT2AMAPK1
Allyl Cinnamate SCHEMBL45457 0.83 APP (0.63) MAPTALDH1A1MEN1KMT2AMAPK1
Allyl Cinnamate SCHEMBL45456 0.83 APP (0.63) MAPTALDH1A1MEN1KMT2AMAPK1
Allyl Cinnamate SCHEMBL30689543 0.83 APP (0.63) MAPTALDH1A1MEN1KMT2AMAPK1
SCHEMBL14560098 0.82 GSK3B (0.56) MAPTALDH1A1MEN1KMT2AMAPK1
SCHEMBL11873136 0.81 APP (0.50) MAPTALDH1A1MEN1KMT2AMAPK1
SCHEMBL7060060 0.80 MEN1 (0.62) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL2705439 0.80 MEN1 (0.62) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL2705437 0.80 MEN1 (0.62) MAPTALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070916-A1 Dihydropyrancarboxamides and uses thereof SCHREIBER STUART L 2008-03-20 US disclosed
US-7186709-B2 Subjecting a vinyl ethers and an unsaturated ketoester to suitable conditions to generate a scaffold having the core dihydropyrancarboxamide or dihydropyrancarboxylic ester or acid; anticarcinogenic agents PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2007-03-06 US disclosed
US-20040059138-A1 Dihydropyrancarboxamides and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040059138-A1 Dihydropyrancarboxamides and uses thereof CCNA1, DPYD, DHFR MAPT 3317/4885ALDH1A1 71/4885MEN1 2407/4885
US-20080070916-A1 Dihydropyrancarboxamides and uses thereof CCNA1, DPYD, DHFR MAPT 2639/4885ALDH1A1 140/4885MEN1 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.